BTG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.190000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.782600E-01
Normal-vs-Stage2
4.397000E-01
Normal-vs-Stage3
4.841200E-01
Normal-vs-Stage4
2.310400E-01
Stage1-vs-Stage2
9.447600E-02
Stage1-vs-Stage3
6.822200E-01
Stage1-vs-Stage4
8.751600E-01
Stage2-vs-Stage3
5.649800E-01
Stage2-vs-Stage4
2.607400E-01
Stage3-vs-Stage4
7.711800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.327800E-01
Normal-vs-AfricanAmerican
3.723400E-01
Normal-vs-Asian
3.841400E-01
Caucasian-vs-AfricanAmerican
8.661400E-01
Caucasian-vs-Asian
9.441400E-01
AfricanAmerican-vs-Asian
9.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.869200E-01
Normal-vs-Female
3.266000E-01
Male-vs-Female
7.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.709400E-01
Normal-vs-Age(41-60Yrs)
1.757380E-01
Normal-vs-Age(61-80Yrs)
5.267200E-01
Normal-vs-Age(81-100Yrs)
9.656200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.827200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.054600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.788400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.002000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.964100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.817500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.371800E-01
Normal-vs-Daily Drinker
7.260200E-01
Normal-vs-Weekly Drinker
3.561800E-01
Normal-vs-Occasional Drinker
3.985800E-01
Normal-vs-Social Drinker
4.505200E-01
Non Drinker-vs-Daily Drinker
9.248400E-01
Non Drinker-vs-Weekly Drinker
1.388410E-01
Non Drinker-vs-Occasional Drinker
4.837200E-01
Non Drinker-vs-Social Drinker
2.418600E-01
Daily Drinker-vs-Weekly Drinker
2.054200E-01
Daily Drinker-vs-Occasional Drinker
5.837600E-01
Daily Drinker-vs-Social Drinker
3.253000E-01
Weekly Drinker-vs-Occasional Drinker
3.715600E-01
Weekly Drinker-vs-Social Drinker
8.163000E-01
Occasional Drinker-vs-Social Drinker
5.500800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.666000E-01
Normal-vs-Grade 2
4.279700E-02
Normal-vs-Grade 3
4.891800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.662200E-01
Grade 1-vs-Grade 3
5.328400E-01
Grade 1-vs-Grade 4
2.666000E-01
Grade 2-vs-Grade 3
4.547800E-01
Grade 2-vs-Grade 4
4.279700E-02
Grade 3-vs-Grade 4
4.891800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.237200E-01
Normal-vs-NonDiabetic
4.045400E-01
Diabetic-vs-NonDiabetic
2.239400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.508580E-01
Normal-vs-NoPancreatitis
4.790400E-01
Pancreatitis-vs-NoPancreatitis
2.127200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.303800E-01
Normal-vs-N1
4.325000E-01
N0-vs-N1
4.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.690400E-01
Normal-vs-TP53-NonMutant
7.086000E-01
TP53-Mutant-vs-TP53-NonMutant
9.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
